InSilixa Scores $13M in Funding

October 23, 2014

Share:

InSilixa is developing high-performance CMOS biochips for microarray technology, qPCR and DNA sequencing. Its point-of-care systems are designed to rapidly identify infecting pathogens in clinical samples and simultaneously verify the absence or presence of genetic mutations that result in antibiotic resistance.